Jordan Dozier, MD, is a fellowship-trained, board-certified thoracic surgeon at Ochsner Health whose practice focuses thoracic cancer and complex benign disease. He integrates advanced robotic & thoracoscopic/laparoscopic (camera-based) techniques to treat conditions of the lung, mediastinum, esophagus, pleura, diaphragm and airway. He also performs abdominal surgeries including the surgical management of hiatal hernias and reflux disease.

He also treats acquired (trauma) and congenital diseases of the chest wall. In fact, he is one of few thoracic surgeons in the gulf-south that treats adult chest wall deformities including pectus excavatum and performs minimally invasive Nuss procedures for appropriate patients.

Dr. Dozier has a particular clinical interest in expanding access to early detection and treatment for lung cancer. He is active in promoting lung cancer screening across Louisiana, which will catch disease at an earlier stage and improve survival in a historically under-screened region.

Dr. Dozier completed his thoracic surgery fellowship at The Ohio State University and his general surgery residency at Rutgers New Jersey Medical School. He also completed a two-year research fellowship at Memorial Sloan Kettering focused on immunotherapy for thoracic malignancies. His academic work has resulted in multiple publications and presentations at national & international meetings. He views thoracic surgery as a discipline that requires lifelong learning and refinement and remains active in the Society of Thoracic Surgeons while mentoring trainees on scholarly projects.

Ochsner Health is ranked among the nation’s top 10% in Pulmonology and Lung Surgery by U.S. News & World Report, with Ochsner Medical Center rated as “High Performing” in lung cancer surgery. Ochsner's thoracic surgery program is recognized as a 3-star program by the Society of Thoracic Surgeons, placing it in the top 2.5% of programs in North America for quality and outcomes. Additionally, Ochsner's innovative single-event anesthesia program diagnoses and treats lung cancer in a single day, reducing patient wait times and minimizing anesthesia exposure.